Furthermore, a recent meta-analysis with low-grade glioma as well as glioblastoma patients including the aforementioned studies showed that among TERT promotor mutated low-grade gliomas, MGMT promotor methylation was associated with improved overall survival [18]. This evidence concerns the gene TERT and glioblastoma.